● DuChemBio Co. Ltd., distributes and supplies radiopharmaceuticals and multimodality imaging systems in South Korea. ● Established in 2002, it now has five (5) cyclotron facilities in Seoul producing FDG, FT-CIT, FLT. ● It has an existing license for the production of 18F-florbetaben (FBB) for Alzheimer's diagnosis. ● It has revenue sharing with at least ten (10) PET-CT sites in South Korea. In the Philippines, K Health Corporation, a subsidiary of DuChemBio, started its operation in November 2015 with a capacity of 100 doses a day. It is compliant with national and international policies on science, technology, and healthcare.